Immunology of Allergic Rhinitis,or a Nose for Treatment

Meltzer EO Zeiger RS Schatz M , Chronic rhinitis in infants and children: Etiologic, diagnostic and therapeutic considerations. Pediatr Clin North Am 1983; 30: 847

Wihl JA Brofeldt S Gronberg H Borum P Mygind N . Blind study of basophilic cells in nasal smears from patients with grass pollen hay fever. Eur J Respir Dis 1983; 64 (Suppl 128): 383–6

Naclerio RM Meir HL Kagey-Sobotka A , Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis 1983; 128: 597–603

Naclerio RM Togins RG Proud D , Inflammatory mediators in late antigen-induced rhinitis. N Engl J Med 1985; 313: 65–70

Rucci L Cirri-Borghi B Pateleo T Cagnoli A . Effect of vidian nerve stimulation on nasal and maxillary sinus mucosa. A light electron microscope study. J Laryngol Oto, 1984; 98: 597–607

Secher C Kirkegaard J Borman P Maansson I Osterhammel P Mygind N . Significance of H₁ and H₂ receptors in the nose: rationale for topical use of combined antihistamine preparations. J Allergy Clin Immunol 1982; 70: 211–18

Enerbäck L . Mast cells in the rat gastrointestinal mucosa. 1. Effects of fixation. Acta Path Microbiol Scand 1966; 66: 289–302

Kawabori S Okuda M Unno T . Mast cells in allergic nasal epithelium and lamina propria before and after provocation. Clin Allergy 1983; 13: 181–9

Bisgard H Bende M Olssen P . Leukotriene D₄ increases blood flow in humans. Prostaglandins 1984; 27: 599–604

Shaw RJ Fitzharris P Cromwell O Wardlaw AJ Kay AB . Allergin induced release of sulphidopeptide Leukotrines (SRS/A) and LTB₄ in allergic rhinitis. Allergy 1984; 40: 1–6

Shaw RJ Walsh GM Cromwell O Moobel R Spry CJF Kay AB . Activated human eosinophilis generated SRS-A leukotrienes following IgG-dependent stimulation. Nature 1985; 316: 150–2

Norman PS Naclerio RM Creticos PS Togias A Lichtenstein LM . Mediator release after allergic and physical nasal challenges. Int Arch Allergy Appl Immunol 1985; 77: 57–63

Kay AB . Specific and nonspecific triggers in bronchial asthma. J R Soc Med 1985; 78: 82–5

Baumgarten CR Alkis O Togiars G , Influx of kini-of kininogens into nasal secretions after antigen challenge of allergic individuals. J. Clin Invest 1985; 76: 191–7

Johnson LK Longenecker JP Baxter JD Dallman MF Widmaier EP Eberhardt NL . Glucocorticoid action. A mechanism involving nuclear and non-nuclear pathways. Br J Dermatol 1982; 107 (Suppl 23): 6–23

Schleimer RP MacGlashan DW Jr Gillespie E Lichtenstein LM . Inhibition of basophil histamine released by anti-inflammatory steroids. J. Immunol 1982; 129: 1632–6.

Schleimer RP Schulman ES MacGlashan DW Jr , Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest 1983; 71: 1830–5.

Robin JL Seldin DC Austen KF Lewis RA . Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids. J Immunol 1985; 135: 2719–26

Clark TJH Mygind N Selroos O . Corticosteroid treatment in allergic airway diseases. Eur J Respir Dis 1982; 63 (Suppl 122): 00–0

Brandon ML Weiner M . Clinical investigation of terferadine, a non-antihistamine. Ann Allergy 1980; 44: 71–5

Van Wanwe J Awonters F Niemegeers CJ Janssen F Van Micten JM Janssen PAJ . In vivo pharmacology of astemizole, a new type of H₁-antihistamine compound. Arch Int Pharmacodyn Ther 1981; 251: 29–51

Bateman DN Chapman PH Rawlins MD . The effects of astemizole on histamine-induced weal and flare. Eur J Clin Pharmacol 1983; 25: 547–51

Howarth PH Emmanual MB Holgate ST . Astemizole, a potent histamine H₁-receptor antagonist: effect in allergic rhinoconjunctivitis on antigen and histamine wheal responses and relationship to serum levels. Br J Clin Pharmacol 1984; 18: 1–8

Girrard JP Sommacal-Schopf D Bigliardi P Henaner S . Double-blind comparison of astemizole, teferadine, and placebo in hay fever with special regard to onset of action. Ann Allergy 1985; 55: 284

Howarth GH Holgate ST . Comparative trial of two non-sedative H₁-antihistamine, terferadine and astemizole, for hay fever. Thorax 1984; 29: 668–72

Wood SF . A comparative study of astemizole and terferadin in the maintenance therapy of hay fever. Pharmacotherapeutica 1984: 3 (Suppl 2): 51

Auty RM Bentley S Eady RP Edwards AM Orr TSC . Nedocromil sodium (Tilade) a novel modulator of inflammation for the treatment of bronchial asthma. Ann Allergy 1985; 55: 256

Shaw RJ Youngchaiyud P Orr TSC , Nedocrimil a mucosal and connective tissue mast cell stabiliser, inhibits allergen and exercise induced asthma. Thorax 1985; 40: 219

Roberts JA Thomson NC . Attenuation of exercise induced asthma by pretreatment with nedocromil sodium and minocromil. Clin Allergy 1985; 15: 377–81

Lal S Malhotra S Gribben D Hodder D . Nedocromil sodium a new drug for the management of bronchial asthma. Thorax 1984; 39: 809–12

Warner JO . Immunotherapy. In: Lessof MH , ed. Allergy, immunological and clinical aspects London: John Wiley, 1984: 447–64

Mygind N . Immunotherapy in nasal allergy. Oxford: Blackwell Scientific, 1978